Literature DB >> 19432791

Joint modeling for cognitive trajectory and risk of dementia in the presence of death.

Binbing Yu1, Pulak Ghosh.   

Abstract

Dementia is characterized by accelerated cognitive decline before and after diagnosis as compared to normal aging. It has been known that cognitive impairment occurs long before the diagnosis of dementia. For individuals who develop dementia, it is important to determine the time when the rate of cognitive decline begins to accelerate and the subsequent gap time to dementia diagnosis. For normal aging individuals, it is also useful to understand the trajectory of cognitive function until their death. A Bayesian change-point model is proposed to fit the trajectory of cognitive function for individuals who develop dementia. In real life, people in older ages are subject to two competing risks, e.g., dementia and dementia-free death. Because the majority of people do not develop dementia, a mixture model is used for survival data with competing risks, which consists of dementia onset time after the change point of cognitive function decline for demented individuals and death time for nondemented individuals. The cognitive trajectories and the survival process are modeled jointly and the parameters are estimated using the Markov chain Monte Carlo method. Using data from the Honolulu Asia Aging Study, we show the trajectories of cognitive function and the effect of education, apolipoprotein E 4 genotype, and hypertension on cognitive decline and the risk of dementia.

Entities:  

Mesh:

Year:  2009        PMID: 19432791      PMCID: PMC3036971          DOI: 10.1111/j.1541-0420.2009.01261.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  10 in total

1.  Estimation of bivariate measurements having different change points, with application to cognitive ageing.

Authors:  C B Hall; J Ying; L Kuo; M Sliwinski; H Buschke; M Katz; R B Lipton
Journal:  Stat Med       Date:  2001-12-30       Impact factor: 2.373

2.  Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.

Authors:  Philip D Harvey; Michael F Green; Susan R McGurk; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2003-02-18       Impact factor: 4.530

3.  An investigation of ACE as a risk factor for dementia and cognitive decline in the general population.

Authors:  A G Yip; C Brayne; D Easton; D C Rubinsztein
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

4.  Rate of memory decline in AD is related to education and occupation: cognitive reserve?

Authors:  Y Stern; S Albert; M X Tang; W Y Tsai
Journal:  Neurology       Date:  1999-12-10       Impact factor: 9.910

5.  Random change point model for joint modeling of cognitive decline and dementia.

Authors:  Hélène Jacqmin-Gadda; Daniel Commenges; Jean-François Dartigues
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

6.  Terminal decline in cognitive function.

Authors:  R S Wilson; L A Beckett; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

7.  A penalized likelihood approach for arbitrarily censored and truncated data: application to age-specific incidence of dementia.

Authors:  P Joly; D Commenges; L Letenneur
Journal:  Biometrics       Date:  1998-03       Impact factor: 2.571

8.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

9.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study.

Authors:  L White; H Petrovitch; G W Ross; K H Masaki; R D Abbott; E L Teng; B L Rodriguez; P L Blanchette; R J Havlik; G Wergowske; D Chiu; D J Foley; C Murdaugh; J D Curb
Journal:  JAMA       Date:  1996-09-25       Impact factor: 56.272

10.  Education delays accelerated decline on a memory test in persons who develop dementia.

Authors:  C B Hall; C Derby; A LeValley; M J Katz; J Verghese; R B Lipton
Journal:  Neurology       Date:  2007-10-23       Impact factor: 9.910

  10 in total
  11 in total

1.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.

Authors:  Justin E Karr; Raquel B Graham; Scott M Hofer; Graciela Muniz-Terrera
Journal:  Psychol Aging       Date:  2018-03

3.  Implications of Lifecourse Epidemiology for Research on Determinants of Adult Disease.

Authors:  Sze Liu; Richard N Jones; M Maria Glymour
Journal:  Public Health Rev       Date:  2010-11

4.  Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study.

Authors:  Ge Li; Eric B Larson; Jane B Shofer; Paul K Crane; Laura E Gibbons; Wayne McCormick; James D Bowen; Mary Lou Thompson
Journal:  J Am Geriatr Soc       Date:  2017-09-21       Impact factor: 5.562

5.  Multi-stage transitional models with random effects and their application to the Einstein aging study.

Authors:  Changhong Song; Lynn Kuo; Carol A Derby; Richard B Lipton; Charles B Hall
Journal:  Biom J       Date:  2011-10-21       Impact factor: 2.207

6.  Age Profiles of Cognitive Decline and Dementia in Late Life in the Aging, Demographics, and Memory Study.

Authors:  Christine E Walsh; Yang C Yang; Katsuya Oi; Allison Aiello; Daniel Belsky; Kathleen Mullan Harris; Brenda L Plassman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2022-10-06       Impact factor: 4.942

7.  Semicompeting risks in aging research: methods, issues and needs.

Authors:  Ravi Varadhan; Qian-Li Xue; Karen Bandeen-Roche
Journal:  Lifetime Data Anal       Date:  2014-04-12       Impact factor: 1.588

Review 8.  Modeling cognitive trajectories within longitudinal studies: a focus on older adults.

Authors:  Joshua R Steinerman; Charles B Hall; Martin J Sliwinski; Richard B Lipton
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

9.  Bayesian joint modelling of longitudinal and time to event data: a methodological review.

Authors:  Maha Alsefri; Maria Sudell; Marta García-Fiñana; Ruwanthi Kolamunnage-Dona
Journal:  BMC Med Res Methodol       Date:  2020-04-26       Impact factor: 4.615

10.  Using joint models to disentangle intervention effect types and baseline confounding: an application within an intervention study in prodromal Alzheimer's disease with Fortasyn Connect.

Authors:  Floor M van Oudenhoven; Sophie H N Swinkels; Tobias Hartmann; Hilkka Soininen; Anneke M J van Hees; Dimitris Rizopoulos
Journal:  BMC Med Res Methodol       Date:  2019-07-25       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.